159 related articles for article (PubMed ID: 9647356)
21. Disposition and absorption of hydroxychloroquine enantiomers following a single dose of the racemate.
McLachlan AJ; Tett SE; Cutler DJ; Day RO
Chirality; 1994; 6(4):360-4. PubMed ID: 8068494
[TBL] [Abstract][Full Text] [Related]
22. Effect of experimental diabetes mellitus on the pharmacokinetics of atenolol enantiomers in rats.
Mehvar R
J Pharm Sci; 1991 Mar; 80(3):207-11. PubMed ID: 2051334
[TBL] [Abstract][Full Text] [Related]
23. Stereoselective Pharmacokinetics and Chiral Inversion of Ibuprofen in Adjuvant-induced Arthritic Rats.
Ikuta H; Kawase A; Iwaki M
Drug Metab Dispos; 2017 Mar; 45(3):316-324. PubMed ID: 27927688
[TBL] [Abstract][Full Text] [Related]
24. Selective effect of adjuvant arthritis on the disposition of propranolol enantiomers in rats detected using a stereospecific HPLC assay.
Piquette-Miller M; Jamali F
Pharm Res; 1993 Feb; 10(2):294-9. PubMed ID: 8456080
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics of hydroxychloroquine and chloroquine during treatment of rheumatic diseases.
Furst DE
Lupus; 1996 Jun; 5 Suppl 1():S11-5. PubMed ID: 8803904
[TBL] [Abstract][Full Text] [Related]
26. Bioequivalence of chiral drugs. Stereospecific versus non-stereospecific methods.
Mehvar R; Jamali F
Clin Pharmacokinet; 1997 Aug; 33(2):122-41. PubMed ID: 9260035
[TBL] [Abstract][Full Text] [Related]
27. Hydroxychloroquine hindering of diabetic isletopathy carries its signature on the inflammatory cytokines.
Abdel-Hamid AA; El-Firgany Ael-D
J Mol Histol; 2016 Apr; 47(2):183-93. PubMed ID: 26872459
[TBL] [Abstract][Full Text] [Related]
28. Enantioselective analysis of the metabolites of hydroxychloroquine and application to an in vitro metabolic study.
Cardoso CD; Bonato PS
J Pharm Biomed Anal; 2005 Apr; 37(4):703-8. PubMed ID: 15797791
[TBL] [Abstract][Full Text] [Related]
29. A cross-sectional study of hydroxychloroquine concentrations and effects in people with systemic lupus erythematosus.
Carmichael SJ; Day RO; Tett SE
Intern Med J; 2013 May; 43(5):547-53. PubMed ID: 23425382
[TBL] [Abstract][Full Text] [Related]
30. Novel function of hydroxychloroquine: Down regulation of T follicular helper cells in collagen-induced arthritis.
Han J; Zhou Q; Li X; He J; Han Y; Jie H; He Y; Sun E
Biomed Pharmacother; 2018 Jan; 97():838-843. PubMed ID: 29136759
[TBL] [Abstract][Full Text] [Related]
31. Development of a chiral HPLC method for the separation and quantification of hydroxychloroquine enantiomers.
Xiong X; Wang K; Tang T; Fang J; Chen Y
Sci Rep; 2021 Apr; 11(1):8017. PubMed ID: 33850241
[TBL] [Abstract][Full Text] [Related]
32. Safety of hydroxychloroquine in pregnant patients with connective tissue diseases: a study of one hundred thirty-three cases compared with a control group.
Costedoat-Chalumeau N; Amoura Z; Duhaut P; Huong DL; Sebbough D; Wechsler B; Vauthier D; Denjoy I; Lupoglazoff JM; Piette JC
Arthritis Rheum; 2003 Nov; 48(11):3207-11. PubMed ID: 14613284
[TBL] [Abstract][Full Text] [Related]
33. Hydroxychloroquine reduces risk of incident diabetes mellitus in lupus patients in a dose-dependent manner: a population-based cohort study.
Chen YM; Lin CH; Lan TH; Chen HH; Chang SN; Chen YH; Wang JS; Hung WT; Lan JL; Chen DY
Rheumatology (Oxford); 2015 Jul; 54(7):1244-9. PubMed ID: 25587177
[TBL] [Abstract][Full Text] [Related]
34. Effect of early phase adjuvant arthritis on hepatic P450 enzymes and pharmacokinetics of verapamil: an alternative approach to the use of an animal model of inflammation for pharmacokinetic studies.
Ling S; Jamali F
Drug Metab Dispos; 2005 Apr; 33(4):579-86. PubMed ID: 15659540
[TBL] [Abstract][Full Text] [Related]
35. Enantioselective determination of hydroxychloroquine and its major metabolites in urine and the observation of a reversal in the (+)/(-)-hydroxychloroquine ratio.
Fieger H; Iredale J; Wainer IW
Chirality; 1993; 5(2):65-70. PubMed ID: 8343344
[TBL] [Abstract][Full Text] [Related]
36. Steady-state pharmacokinetics of hydroxychloroquine in patients with cutaneous lupus erythematosus.
Al-Rawi H; Meggitt SJ; Williams FM; Wahie S
Lupus; 2018 Apr; 27(5):847-852. PubMed ID: 28862574
[TBL] [Abstract][Full Text] [Related]
37. Hydroxychloroquine improves insulin sensitivity in obese non-diabetic individuals.
Mercer E; Rekedal L; Garg R; Lu B; Massarotti EM; Solomon DH
Arthritis Res Ther; 2012 Jun; 14(3):R135. PubMed ID: 22676348
[TBL] [Abstract][Full Text] [Related]
38. Associations of hydroxychloroquine use with lipid profiles in rheumatoid arthritis: pharmacologic implications.
Kerr G; Aujero M; Richards J; Sayles H; Davis L; Cannon G; Caplan L; Michaud K; Mikuls T
Arthritis Care Res (Hoboken); 2014 Nov; 66(11):1619-26. PubMed ID: 24692402
[TBL] [Abstract][Full Text] [Related]
39. PDE5 Inhibitor Tadalafil and Hydroxychloroquine Cotreatment Provides Synergistic Protection against Type 2 Diabetes and Myocardial Infarction in Mice.
Wang R; Xi L; Kukreja RC
J Pharmacol Exp Ther; 2017 Apr; 361(1):29-38. PubMed ID: 28123046
[TBL] [Abstract][Full Text] [Related]
40. Stereoselective pharmacokinetics of [14C]-labeled KE-298, a new anti-rheumatic drug, in rats.
Yoshida H; Kohno Y; Endo H; Hasegawa M; Suwa T
Chirality; 1996; 8(3):258-63. PubMed ID: 8777146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
